We found 195 records for "Financial"

Articles

AZ points to potential in cancer at strategy update

19th November 2014

 AZ points to potential in cancer at strategy updateArticles

AstraZeneca (AZ) predicted yesterday that its "industry-leading" cancer portfolio would account for a quarter of its revenues in 2023 and is now considered its sixth growth platform.Just six months ago...

Read more

Cancer Drugs Fund budget increased – but pharma prices to be challenged

28th August 2014

 Cancer Drugs Fund budget increased – but pharma prices to be challengedArticles

England's Cancer Drugs Fund is to see its annual budget increased by 40 per cent – but 'excessively priced' drugs could be removed from the list if companies refuse to...

Read more

Tunnah’s musings: Does pharma put profits before patients?

14th August 2014

 Tunnah’s musings: Does pharma put profits before patients?Articles

As the pharma industry repeatedly comes under fire for pricing new medicines out of the reach of cash-strapped healthcare systems, Paul Tunnah asks the difficult question of whether it should...

Read more

Translation from research to clinical significance - a due-diligence analysis

1st August 2014

 Translation from research to clinical significance - a due-diligence analysis Articles

Translational research partnerships help turn academic excellence into new treatments for patients – but they require due diligence at every step along the way.The general public perceives research to be...

Read more

News

RB spin-out Indivior says addiction pipeline will deliver

21st November 2014

 RB spin-out Indivior says addiction pipeline will deliverNews

Earlier this week, Reckitt Benckiser (RB) made good on its promise to spin-out its pharmaceutical business into a new speciality drugmaker - to be called Indivior - that should be...

Read more

Pfizer-Merck cancer deal reduces likelihood of AZ merger

18th November 2014

 Pfizer-Merck cancer deal reduces likelihood of AZ mergerNews

Pfizer has announced an agreement with Merck to co-develop a novel anti-PD-L1 antibody for various cancers.Merck will receive an initial payment of $850 million, with further payments of up to...

Read more

Cancer drugs may be cut after Cancer Drugs Fund review

14th November 2014

 Cancer drugs may be cut after Cancer Drugs Fund reviewNews

Several drugs on NHS England's (NHSE) Cancer Drugs Fund (CDF) list could be dropped following the review of its Standard Operating Procedure to include a value assessment component.The change affects...

Read more

Minister calls for NHS to trim costs by £10bn

14th November 2014

 Minister calls for NHS to trim costs by £10bnNews

UK Health Secretary Jeremy Hunt has challenged NHS leaders to rethink the way its £113bn budget is spent, outlining a series of measures that he says could save the service...

Read more

White Papers

Healthcare Innovation: the big ideas shaping the future of pharma

17th November 2014

 Healthcare Innovation: the big ideas shaping the future of pharmaWhite Papers

The transformation taking place in healthcare is challenging for everyone and adaptability is key for the pharma industry's continued success.Long production cycles, concentration on specialist drugs with high price tags,...

Read more

Redefining Market Access - Effective Value Engagement

3rd December 2013

 Redefining Market Access - Effective Value EngagementWhite Papers

Phenestra's latest white paper highlights the challenges in market access and reimbursement for every company involved in developing new and innovative drugs.Today, every pharmaceutical company has the patient at the...

Read more

Audio & Video

Dec 8th: Live webinar - The Price is Right? - Delivering UK access for niche patient populations

  With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving (final changes to be announced in the coming weeks) – what is next, what are the...

Read more

View the recorded webinar - The future of UK pharma

The global pharmaceutical market passes a significant milestone in 2014: reaching one trillion US dollars in total value. IMS Health forecasts the global market will see a compound average growth...

Read more

Events

Empowering allied health professionals to transform health and care services

9th December 2014

Empowering allied health professionals to transform health and care services

This one-day conference highlights the active role that Allied Health Professionals have in delivering service transformation. We will explore how pioneering AHPs are driving forward professional leadership, service realignment and...

Read more

The Microbiome Forum: Asia

19th January 2015 - 20th January 2015

The Microbiome Forum: Asia

Following our highly acclaimed London & San Diego meetings the first Microbiome Forum: Asia istaking place in Kuala Lumpur on 19th & 20th January, 2015. Hear about the very latest...

Read more

9th Clinical Trial Billing & Research Compliance Conference

8th February 2015

9th Clinical Trial Billing & Research Compliance Conference

With Sponsors, CROs, Sites, Physician Practices and Academic Medical Centers at the table discussing the revenue cycle and the impact of clinical trial billing, how can you go wrong? Together...

Read more

Ageing and Health: Policymaking in an era of longevity

9th February 2015

Ageing and Health: Policymaking in an era of longevity

How can societies meet the health, care and economic challenges of global ageing? One in nine people in the world is 60 or older and this is expected to rise to...

Read more

Press Releases

Gower's latest Pharmaceutical and Healthcare Industry Catalogue

18th September 2014

Gower's latest Pharmaceutical and Healthcare Industry Catalogue

The latest Gower Pharmaceutical and Healthcare Industry Books Catalogue is now available online! Expanding on the Pharma and Health content this year, we have added details of books from our Governance & Leadership...

Read more

Aqurance launches Market Research & Predictive Analytics Services

3rd July 2014

Aqurance launches Market Research & Predictive Analytics Services

Athens, GR, July 02, 2014: Aqurance, a dynamic startup that specializes inLife Sciences consulting and technology implementation services, has recently announced the launch of a new business department, the Market...

Read more